The pathogens considered most dangerous to human health included Aspergillus fumigatus, which comes from mold and infects the ...

F2G submitted its initial approval application with data from the first 100 patients enrolled in a phase 2b study of the drug ...

F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...

It typically occurs in people with weakened immune systems and can be fatal. Initial treatment generally involves existing ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a group of ...

Two new research studies are addressing the rising threat of fungal infections, which can be very difficult to treat. One study has examined ... | Cell And Molecular Biology ...

Like bacteria with antibiotics, many fungal pathogens are increasingly developing resistance to antifungal drugs, scientists have highlighted this alarming trend while  emphasising the need to include ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a renowned group ...

After an outbreak of Valley fever at a music festival in California, experts say new cases will likely continue into the fall ...

Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a group of scientists from the around the world has warned. According to the scientists ...

(Reuters) - F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments ...